Efficacy of the monoclonal antibody EGFR inhibitors for the treatment of metastatic colorectal cancer

Two anti-epidermal growth factor receptor (EGFR) monoclonal antibodies (MoAbs) have been approved in Canada for the treatment of metastatic colorectal cancer (mCRC) – cetuximab, a mouse-human chimeric MoAb, and panitumumab, a fully human MoAb. This paper reviews the efficacy of the anti-EGFR monoclo...

Descripción completa

Detalles Bibliográficos
Autores principales: Fakih, M., Wong, R.
Formato: Texto
Lenguaje:English
Publicado: Multimed Inc. 2010
Materias:
Medical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2901794/
https://www.ncbi.nlm.nih.gov/pubmed/20680105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2901794/
https://www.ncbi.nlm.nih.gov/pubmed/20680105

Ejemplares similares